ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $672,000 | +1039.0% | 3,020 | +1098.4% | 0.00% | – |
| Q4 2021 | $59,000 | +18.0% | 252 | +16.1% | 0.00% | – |
| Q3 2021 | $50,000 | -65.8% | 217 | -69.5% | 0.00% | -100.0% |
| Q2 2021 | $146,000 | 0.0% | 711 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | +82.5% | 711 | +91.6% | 0.00% | – |
| Q4 2020 | $80,000 | +142.4% | 371 | +103.8% | 0.00% | – |
| Q3 2020 | $33,000 | -77.4% | 182 | -77.0% | 0.00% | -100.0% |
| Q2 2020 | $146,000 | -97.9% | 793 | -96.7% | 0.00% | -96.4% |
| Q3 2018 | $6,815,000 | +56691.7% | 24,101 | +30798.7% | 0.03% | – |
| Q4 2016 | $12,000 | -86.5% | 78 | -88.9% | 0.00% | – |
| Q3 2016 | $89,000 | -96.1% | 704 | -96.6% | 0.00% | -100.0% |
| Q3 2015 | $2,257,000 | +436.1% | 20,607 | +355.8% | 0.01% | +500.0% |
| Q1 2015 | $421,000 | -92.0% | 4,521 | -92.9% | 0.00% | -91.3% |
| Q4 2014 | $5,236,000 | +194.2% | 63,970 | +130.7% | 0.02% | +155.6% |
| Q3 2014 | $1,780,000 | +210.6% | 27,730 | +208.3% | 0.01% | +200.0% |
| Q4 2013 | $573,000 | – | 8,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |